These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4390900)

  • 21. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.
    Stossel TP; Alper CA; Rosen FS
    J Exp Med; 1973 Mar; 137(3):690-705. PubMed ID: 4631990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytes.
    Guckian JC; Christensen GD; Schweinle JE; Fine DP
    J Immunol; 1981 Oct; 127(4):1659-65. PubMed ID: 7276577
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: studies on selected complement components and immunoglobulins.
    Bjornson AB; Gaston MH; Zellner CL
    J Pediatr; 1977 Sep; 91(3):371-8. PubMed ID: 19568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsonic activity in human serum deficient in C2.
    Johnson FR; Agnello V; Williams RC
    J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482
    [No Abstract]   [Full Text] [Related]  

  • 28. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.
    Johnston RB; Klemperer MR; Alper CA; Rosen FS
    J Exp Med; 1969 Jun; 129(6):1275-90. PubMed ID: 4181833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
    Drake WP; Pokorney DR; Mardiney MR
    J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
    [No Abstract]   [Full Text] [Related]  

  • 31. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    Root RK; Ellman L; Frank MM
    J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402
    [No Abstract]   [Full Text] [Related]  

  • 32. DEMONSTRATION BY FLUORESCENCE MICROSCOPY OF ADSORPTION ONTO BACTERIA OF A HEAT-LABILE FACTOR FROM GUINEA PIG SERUM.
    HIRSCH JG
    J Immunol; 1964 Jan; 92():155-8. PubMed ID: 14139538
    [No Abstract]   [Full Text] [Related]  

  • 33. Formation and function of a complex of the C3 proactivator with a protein from cobra venom.
    Cooper NR
    J Exp Med; 1973 Feb; 137(2):451-60. PubMed ID: 4734404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in serum opsonic activity and complement levels in pneumococcal disease.
    Giebink GS; Dee TH; Kim Y; Quie PG
    Infect Immun; 1980 Sep; 29(3):1062-6. PubMed ID: 6903559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement activation in factor D-deficient mice.
    Xu Y; Ma M; Ippolito GC; Schroeder HW; Carroll MC; Volanakis JE
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14577-82. PubMed ID: 11724962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opsonic activity of guinea pig serum is reduced by in vivo administration of carcinogenic nitrosamines.
    Marom Z; Brade V; Colten HR
    J Immunol; 1978 Mar; 120(3):983-5. PubMed ID: 632598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phagocytosis of C3b-coated sheep red blood cells by guinea-pig macrophages in the absence of antibody.
    Segerling M; Hahn H; Opferkuch W
    Immunobiology; 1982; 162(1):39-45. PubMed ID: 7106839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of membrane receptors for C3b and C3d in phagocytosis.
    Ehlenberger AG; Nussenzweig V
    J Exp Med; 1977 Feb; 145(2):357-71. PubMed ID: 833545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.